Lovastatin
37 NDCs across 5 manufacturers|37 Generic,0 Brand
Lovastatin is used to treat coronary artery disease, hypercholesterolemia, hyperlipoproteinemias and hypertriglyceridemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 31, 1987, and the first generic was approved Dec 17, 2001. FDA's Orange Book lists 21 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $26 million on Lovastatin across 2.5 million claims for 629,000 beneficiaries.
Lovastatin is available as 37 NDCs from 5 manufacturers (37 generic, 0 brand), with NADAC prices from $0.04 to $0.06 per EA — a 63% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
37
37G / 0B
Manufacturers
5
competing in market
Price Spread
$0.04 – $0.06
per EA
7d Activity
avg -0.4% WoW · of 37 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Lupin Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
HMG-CoA Reductase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
5 manufacturers producing LOVASTATIN
Frequently Asked Questions
What is Lovastatin used to treat?
Lovastatin is used to treat coronary artery disease, hypercholesterolemia, hyperlipoproteinemias and hypertriglyceridemia, per the National Library of Medicine's MED-RT classification.
When did Lovastatin become available as a generic?
FDA approved the first generic Lovastatin (ANDA) on Dec 17, 2001. The Orange Book currently lists 21 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Lovastatin?
In 2024, Medicare Part D spent $26 million on Lovastatin across 2.5 million claims for 629,000 beneficiaries.
How many Lovastatin products are on the market?
The Lovastatin drug market contains 37 NDCs from 5 manufacturers — 37 generic and 0 brand products.
What is the price range for Lovastatin?
NADAC reference prices for Lovastatin range from $0.0365 to $0.0597 per EA — a 63% difference between cheapest and most expensive.
Which manufacturers make Lovastatin?
5 manufacturers list Lovastatin in NADAC. Ranked by number of NDCs, the largest are Lupin Pharmaceuticals Inc. (12), Carlsbad Technology Inc. (11), BluePoint Laboratories (6), Teva Pharmaceuticals USA Inc. (6), Legacy Pharmaceutical Packaging, LLC (2).
How has the price of Lovastatin changed recently?
Over the past 7 days, 11 Lovastatin NDCs rose and 20 fell, with a market-wide average change of -0.4%.